Healthcare -
Biotechnology - NASDAQ - US
$ 40.79
0.841 %
$ 2.64 B
Market Cap
-17.43
P/E
KYMR - OPERATING INCOME
Operating Income KYMR - Kymera Therapeutics, Inc.
-166 M
LAST VALUE
-28.32%
2 YEAR CAGR
-50.48%
5 YEAR CAGR
0.00%
10 YEAR CAGR